Antithrombotic treatment in atrial fibrillation.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Analysis of antithrombotic therapy after cardioembolic stroke due to atrial fibrillation or flutter.Hospital pharmacy · 2013
   Article
2. Clinical use of aspirin in treatment and prevention of cardiovascular disease.Thrombosis · 2012
   Article
3. Incidence of atrial fibrillation in patients with either heart failure or acute myocardial infarction and left ventricular dysfunction: a cohort study.BMC cardiovascular disorders · 2011
   Article
4. Stroke prevention in the high-risk atrial fibrillation patient: Medical management.Current cardiology reports · 2011
   Review
5. Antithrombotic medication for cardioembolic stroke prevention.Stroke research and treatment · 2011
   Article
6. Atrial Fibrillation and Hypertension: Mechanistic, Epidemiologic, and Treatment Parallels.Methodist DeBakey cardiovascular journal
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as